2019 / 06

Next Paper
DOI: 10.24075/brsmu.2019.075
Copyright: © 2019 by the authors. Licensee: Pirogov University.
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (CC BY).

ORIGINAL RESEARCH

Hepatoprotective effect of polyphenols in rats with experimental thioacetamide-induced toxic liver pathology

Dergachova DI1, Klein OI1, Marinichev AA1,2, Gessler NN1, Bogdanova ES3, Smirnova MS3, Isakova EP1, Deryabina YI1
About authors

1 Bach Institute of Biochemistry, Federal Research Centre “Fundamentals of Biotechnology” RAS, Moscow, Russia

2 Mendeleyev University of Chemical Technology of Russia, Moscow

3 Vavilov Institute of General Genetics, Moscow, Russia

Correspondence should be addressed: Maria S. Smirnova
Moskvina, 10–226, Khimki, Moscow Region, 141401; ur.ay@oktobrabm

About paper

Funding: the study was supported by the Ministry of Education and Science of the Russian Federation (agreement № 14.616.21.0083, unique project ID: RFMEFI61617X0083).

Acknowledgement: we thank to the Center for Precision Genome Editing and Genetic Technologies for Biomedicine (Moscow) for the genetic research methods.

Author contribution: Dergachova DI — conducting experiments on toxic hepatitis induction, histological analysis, manuscript draft preparation; Klein OI — histological studies, data acquisition and analysis; Marinichev AA — experiments on toxic hepatitis induction, blood sample collection from experimental animals, preparation of histological samples; Gessler NN — conducting experiments on toxic hepatitis induction, blood sample collection from experimental animals, data acquisition and analysis; Bogdanova ES, Smirnova MS — literature analysis, data acquisition and analysis; Isakova EP — conducting experiments on toxic hepatitis induction, literature analysis; Deryabina YI — experiment planning, literature analysis, data acquisition and analysis.

Received: 2019-10-26 Accepted: 2019-11-17 Published online: 2019-11-28
|
  1. Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y. The potential and action mechanism of polyphenols in the treatment of liver diseases. Oxid Med Cell Longev. 2018; 8394818. DOI: 10.1155/2018/8394818.
  2. Raff E, Singal AK. Optimal management of alcoholic hepatitis. Minerva Gastroenterol Dietol. 2014; 60 (1): 25–38.
  3. Riggio O, Ridola L, Pasquale C. World J Gastrointest Pharmacol Ther Hepatic encephalopathy therapy: An overview. 2010; 1 (2): 54–63.
  4. Neuschwander-Tetri BA. Non-alcoholic fatty liver disease. BMC Med. 2017; 15 (1): 45.
  5. Popov VB, Lim JK. Treatment of nonalcoholic fatty liver disease: The role of medical, surgical, and endoscopic weight loss. J Clin Transl Hepatol. 2015; 3 (3): 230–38.
  6. Hong M, Li S, Tan H, Wang N, Tsao SW, Feng Y. Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects. Int J Mol Sci. 2015; 16 (12): 28705–45.
  7. Festi D, Vestito A, Mazzella G, Roda E, Colecchia A. Management of hepatic encephalopathy: focus on antibiotic therapy. Digestion. 2006; 73 (Suppl. 1): 94–101.
  8. Malaguarnera M, Gargante MP, Malaguarnera G, Salmeri M, Mastrojeni S, Rampello L, et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2010; 22 (2): 199–206.
  9. Efrati C, Masini A, Merli M, Valeriano V, Riggio O. Effect of sodium benzoate on blood ammonia response to oral glutamine challenge in cirrhotic patients: a note of caution. Am J Gastroenterol. 2000; 95 (12): 3574–78.
  10. Plauth M, Cabre E, Riggio O, Assis-Camilo M, Pirlich M, Kondrup J, et. al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006; 25 (2): 285–94.
  11. Wong VW, Singal AK. Emerging medical therapies for non-alcoholic fatty liver disease and for alcoholic hepatitis. Transl Gastroenterol Hepatol. 2019; (4): 53.
  12. Minushkin ОN, Maslovsky LV, Bukshuk АА. The use of hepatic protectors in clinical practice. Zh Nevrol Psikhiatr Im SS Korsakova. 2012; 10 (2): 67–72.
  13. Teplova VV, Isakova EP, Klein OI, Dergacheva DI, Gessler NN, Deryabina YI. Natural Polyphenols: Biological Activity, Pharmacological Potential, Means of Metabolic Engineering (Review). Applied Biochemistry and Microbiology. 2018; 54 (3): 221–37.
  14. Quideau S, Deffieux D, Douat-Casassus C, Pouysegu L. Plant polyphenols: chemical properties, biological activities, and synthesis. Angewandte Chemie Intern Edition. 2011; 50 (3): 586–621.
  15. Ma JQ, Li Z, Xie WR, Liu CM, Liu SS. Quercetin protects mouse liver against CCl4-induced inflammation by the TLR2/4 and MAPK/NF-κB pathway. Intern Immunopharm. 2014; 28 (1): 531–39.
  16. Ma JQ, Ding J, Zhao H, Liu CM. Puerarin attenuates carbon tetrachloride-induced liver oxidative stress and hyperlipidaemia in mouse by JNK/c-Jun/CYP7A1 pathway. Basic Clin Pharmacol Toxicol. 2014; 115 (5): 389–95.
  17. Liao CC, Day YJ, Lee HC, Liou JT, Chou AH, Liu FC. ERK signaling pathway plays a key role in baicalin protection against acetaminophen-induced liver injury. Am J Chinese Med. 2017; 45 (1): 105–21.
  18. Wallace MC, Hamesch K, Lunova M, Kim Y, Weiskirchen R, Strnad P, et. al. Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Laboratory Animals. 2015; 49 (S1): 21–9.
  19. Xie Y, Wang G, Wang H, Yao X, Jiang S, Kang A, et. al. Cytochrome P450 dysregulations in thioacetamide-induced liver cirrhosis in rats and the counteracting effects of hepatoprotective agents. Drug Metabolism and Disposition. 2012; 40 (4): 796–802.
  20. Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol. 2014; 37 (1): 118–33.
  21. Seif El-Din SH, El-Lakkany NM, Salem MB, Hammam OA, Saleh S, Botros SS. Resveratrol mitigates hepatic injury in rats by regulating oxidative stress, nuclear factorkappa B, and apoptosis. J Advanc Pharmaceut Technol Res. 2016; 7 (3): 99–104.
  22. Frank GA, Malkov PG, редакторы. 101 shag na puti k uspekhu v gistologii. Leica Microsystems Vetzlar, Germany; 2012. 136 с. Russisn.
  23. Kang MC, Kang SM, Ahn G, Kim KN, Kang N, Samarakoon KW, et. al. Protective effect of a marine polyphenol, dieckol against carbon tetrachlorideinduced acute liver damage in mouse. Environ Toxicol Pharmacol. 2013; 35 (3): 517–23.
  24. Kang MC, Kang SM, Ahn G, Kim KN, Kang N, Samarakoon KW, et. al. Protective effect of a marine polyphenol, dieckol against carbon tetrachlorideinduced acute liver damage in mouse. Environ Toxicol Pharmacol. 2013; 35 (3): 517–23.
  25. Kim DW, Cho HI, Kim KM, Kim YS. Isorhamnetin-3-O-galactoside protects against CCl4-induced hepatic injury in mice Biomolecules Therapeutics. 2012; 20 (4): 406–12.
  26. Huang X, Lian T, Guan X., Liu B, Hao S, Zhang J, et. al. Dihydromyricetin reduces TGF-β via P53 activation-dependent mechanism in hepatocellular carcinoma HepG2 cells. Protein Pept Lett. 2017; 24 (5): 419–24.
  27. Zheng L, Yin L, Xu L, Qi Y, Li H, Xu Y, et. al. Protective effect of dioscin against thioacetamide-induced acute liver injury via FXR/ AMPK signaling pathway in vivo. Biomed Pharmacother. 2018; (97): 481–8. DOI: 10.1016/j.biopha.2017.10.153.